Developmental Programmes (Flow Cytometry)

Open to participation from any laboratory. Predefined increasing cost over a number of years (typically, but not limited to, 5 years). Set number of distributions per financial year. Primary aim of this phase is to further optimise the programme (sample matrix and trial process) and wider ascertain the quality of testing performed in the given area. Identification of problematic testing aspects informs development of a performance monitoring system proposal in preparation for accreditation.

Previously known as ‘pilot’.

Print | Sitemap

 

Follow Us Online: Facebook Twitter LinkedIn Youtube

Available Links: Disclaimer | Privacy Policy | Cookie Policy (This website uses cookies)

Last updated 05/08/2025 © UK NEQAS for Leucocyte Immunophenotyping. Not to be reproduced in whole or part without permission.

UK NEQAS is a Company Limited by Guarantee (No.3012351) and a Registered UK Charity (No.1044013).